Zymeworks (ZYME) Capital Expenditures (2021 - 2026)
Zymeworks (ZYME) reported Capital Expenditures of $100000.0 for Q1 2026, up 525.0% on a YoY basis from $16000.0 in Q1 2025, and down 82.79% sequentially from $581000.0 in Q4 2025.
Zymeworks (ZYME) Capital Expenditures (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Capital Expenditures data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 525.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 20.03% YoY), and the FY2025 full-year result was $1.5 million, down 23.61% from the prior year.
- Capital Expenditures slipped to $100000.0 in Q1 2026, from $581000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $4.2 million in Q1 2022 to a low of -$5.4 million in Q3 2022.
- A 5-year average of $293187.5 and a median of $462000.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures sank 321.1% in 2023 and jumped 525.0% in 2026, its largest moves.
- Tracing ZYME's Capital Expenditures over 5 years: stood at -$474000.0 in 2022, then slumped by 321.1% to -$2.0 million in 2023, then jumped by 115.73% to $314000.0 in 2024, then surged by 85.03% to $581000.0 in 2025, then tumbled by 82.79% to $100000.0 in 2026.
- Business Quant data shows ZYME's Capital Expenditures at $100000.0 in Q1 2026, $581000.0 in Q4 2025, and $410000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | 410,000.00 |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Sep 30, 2024 | 899,000.00 |
| Sep 30, 2024 | 899,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Dec 31, 2023 | -2.00 Mn |
| Dec 31, 2023 | -2.00 Mn |
| Sep 30, 2023 | 930,000.00 |
| Sep 30, 2023 | 930,000.00 |